BioCentury
ARTICLE | Finance

March 12 Quick Takes: Longboard, Prometheus rise after pricing IPOs; plus Monte Rosa, Nano Cures and CalciMedica

March 13, 2021 1:53 AM UTC

A pair of newly public NASDAQ companies traded up on Friday. Prometheus Biosciences Inc. (NASDAQ:RXDX), which raised $190 million in an upsized IPO, rose 33% to $25.29. The GI company raised $130 million in a November 2020 crossover round, and moved its first program into the clinic to treat inflammatory bowel disease.

Shares of Longboard Pharmaceuticals Inc. (NASDAQ:LBPH) ticked up $0.65 to $16.65 after the San Diego-based company raised $80 million in its IPO. Longboard spun out of  Arena Pharmaceuticals Inc. (NASDAQ:ARNA) last year to develop three neuroscience programs. ...